Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-76,446
Closed -$1.91M 10607
2014
Q1
$1.91M Buy
76,446
+61,802
+422% +$1.81M ﹤0.01% 2831
2013
Q4
$421K Buy
14,644
+12,162
+490% +$356K ﹤0.01% 4525
2013
Q3
$82K Sell
2,482
-165,798
-99% -$5.16M ﹤0.01% 6252
2013
Q2
$5.22M Buy
+168,280
New +$4.51M 0.01% 1574

Other funds holding INVA

UBS's INVA Position: Q3 2014 in Review

UBS reduced its Innoviva (INVA) stake by 87% in Q3 2014, selling an estimated $634K and leaving 4,132 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #6405.

UBS first reported a position in INVA in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.87M in Q4 2013. 120 funds tracked by Wall St. Rank hold INVA as of Q3 2014.

  • UBS held 4,132 shares of Innoviva worth $71K as of Q3 2014.
  • UBS sold 27,585 Innoviva shares in Q3 2014, an estimated $634K.
  • Innoviva made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6405 holding.
  • UBS first reported a position in Innoviva in Q2 2013 and has held it in 6 quarters since.
  • UBS's Innoviva position peaked at $1.87M in Q4 2013.
  • 120 funds tracked by Wall St. Rank held Innoviva as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.